A. Engesser

发表

Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Simon C Watkins, F. Westermann, F. Berthold, 2015, Nature.

Mutational dynamics between primary and relapse neuroblastomas

Sven Rahmann, Barbara Hero, Christopher Schröder, 2015, Nature Genetics.

Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment

F. Berthold, M. Fischer, A. Oberthuer, 2017, Neoplasia.

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Roland Eils, Gudrun Schleiermacher, Barbara Hero, 2014, Clinical Cancer Research.

Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum.

W. Burkard, A. Engesser, W. Schaffner, 1997, Pharmaceutica acta Helvetiae.

Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis.

Christoph Bartenhagen, Matthias Fischer, Tanmoy Mondal, 2018, Cancer cell.

Fibroblast growth factor receptors as therapeutic targets in neuroblastoma

Roman K. Thomas, M. Peifer, F. Ikram, 2014 .

Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma

F. Westermann, F. Berthold, M. Fischer, 2016, Molecular oncology.

Risk Estimation and Treatment Strati fi cation of Low-and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

R. Eils, F. Westermann, F. Berthold, 2015 .